Inventor · disambiguated record
Dilini Charmain Gunasekera
Also filed as: GUNASEKERA DILINI CHARMAIN
5 granted patents·5 pending applications·17 citations·filing 2019–2025
77Inventor score
Files withMARENGO THERAPEUTICS INC10
Top patents by PatentIndex Score
10 records- 0195US11965025B2Method of treating solid cancers with bispecific interleukin-anti-TCRß moleculesMARENGO THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·7 cites·26 claims
- 0293US11845797B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2019·Granted Dec 19, 2023·7 cites·34 claims
- 0392US12351632B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2023·Granted Jul 8, 2025·1 cites·33 claims
- 0491US12486326B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2023·Granted Dec 2, 2025·1 cites·10 claims
- 0591US12286477B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Granted Apr 29, 2025·1 cites·29 claims
- 0686US2024301060A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0782US2025340640A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0878US2025215085A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0977US2022064297A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1070US2023227552A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dilini Charmain Gunasekera files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →